BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12161240)

  • 1. Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure.
    Aronson D; Burger AJ
    Am J Cardiol; 2002 Aug; 90(4):435-8. PubMed ID: 12161240
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nesiritide for the treatment of congestive heart failure.
    Iyengar S; Feldman DS; Trupp R; Abraham WT
    Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
    Colbert K; Greene MH
    Crit Care Nurs Q; 2003; 26(1):40-4. PubMed ID: 12669946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
    Emerman CL
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nesiritide therapy for decompensated heart failure.
    Rempher KJ
    Clin Nurse Spec; 2002 May; 16(3):157-9. PubMed ID: 12021617
    [No Abstract]   [Full Text] [Related]  

  • 8. Nesiritide: a review of its use in acute decompensated heart failure.
    Keating GM; Goa KL
    Drugs; 2003; 63(1):47-70. PubMed ID: 12487622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "BNP" for heart failure: role of nesiritide in cardiovascular therapeutics.
    Mills RM; Hobbs RE; Young JB
    Congest Heart Fail; 2002; 8(5):270-3. PubMed ID: 12368590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesiritide: a unique therapeutic cardiac peptide.
    Rayburn BK; Bourge RC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S25-31. PubMed ID: 12439359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure.
    Fitzgerald RL; Cremo R; Gardetto N; Chiu A; Clopton P; Bhalla V; Maisel AS
    Am Heart J; 2005 Sep; 150(3):471-7. PubMed ID: 16169326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
    McCullough PA; Kuncheria J; Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical application of human B-type natriuretic peptide as a therapeutic intervention in the perioperative setting.
    Feldman DS; Sun B
    Heart Fail Rev; 2004 Jul; 9(3):203-8. PubMed ID: 15809818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nesiritide to treat acute decompensated heart failure.
    Hachey DM; Smith T
    Crit Care Nurse; 2003 Feb; 23(1):53-5. PubMed ID: 12640959
    [No Abstract]   [Full Text] [Related]  

  • 17. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide vs nitroglycerin for decompensated congestive heart failure.
    Dunavant S
    JAMA; 2002 Aug; 288(5):571-2; author reply 572-3. PubMed ID: 12150661
    [No Abstract]   [Full Text] [Related]  

  • 20. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.